Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Sep 18, 2020
Document Date
Sep 16, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Filer
Brumm Joshua T